AstraZeneca acquires Caelum Biosciences for $150M
October 8, 2021
WILMINGTON – Pharmaceutical giant AstraZeneca has acquired Caelum Biosciences, a small clinical-stage biotechnology company, for $150 million. The New Jersey-based Caelum was founded by New York-based biopharma company Fortress Biotech […]
chat_bubble0 Comment
visibility1402 Views
AstraZeneca to acquire Alexion for $39B
December 14, 2020
WILMINGTON – The pharmaceutical giant AstraZeneca announced Saturday that it has reached an agreement to acquire rare disease specialist Alexion Pharmaceuticals Inc. for $39 billion, the largest industry deal this […]
chat_bubble0 Comment
visibility1167 Views
Premier Digital Partners
© 2024 Delaware Business Times
